Zydus Fights For Right To Make Generic Strattera

Law360, New York (October 28, 2010, 2:53 PM EDT) -- Zydus Pharmaceuticals USA Inc. has launched a suit seeking permission to manufacture a generic version of Eli Lilly & Co.'s attention deficit hyperactivity disorder drug Strattera, arguing it is not bound by an appellate court's injunction temporarily barring seven other generic makers from producing the drug.

There is no prohibition against Zydus immediately bringing its fully approved generic atomoxetine hydrochloride to the market because there is no threat of it infringing Lilly's patent covering Strattera, which a federal judge found to be invalid for lack of...
To view the full article, register now.